Bhavjot Bindra

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

John Koreth, Ken‐ichi Matsuoka, Haesook T. Kim et al. · New England Journal of Medicine · 2011 · 1.1K citations · Full text

Life Sciences, Cell Biology, Immunology +16

Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation

John Koreth, Kristen E. Stevenson, Haesook T. Kim et al. · Journal of Clinical Oncology · 2012 · 142 citations · Full text

Life Sciences, Hematology, Immunology +17

Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial

Corey Cutler, Haesook T. Kim, Bhavjot Bindra et al. · Blood · 2013 · 121 citations

Life Sciences, Hematology, Immunology +12

A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease

Alex F. Herrera, Haesook T. Kim, Bhavjot Bindra et al. · Biology of Blood and Marrow Transplantation · 2014 · 48 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +16

A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial

John Koreth, Haesook T. Kim, Paulina Lange et al. · Biology of Blood and Marrow Transplantation · 2015 · 31 citations · Full text

Life Sciences, Hematology, Immunology +17